These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 38018421)
21. ATF5 regulates tubulointerstitial injury in diabetic kidney disease via mitochondrial unfolded protein response. Liu Y; Zhang L; Zhang S; Liu J; Li X; Yang K; Yang D; Liu Y; Sun L; Liu F; Xiao L Mol Med; 2023 Apr; 29(1):57. PubMed ID: 37095454 [TBL] [Abstract][Full Text] [Related]
22. Advances in the study of ELABELA in renal physiological functions and related diseases. Liu Y; Jiang M; Li Y; Chen P; Chen X Front Pharmacol; 2023; 14():1276488. PubMed ID: 38026926 [TBL] [Abstract][Full Text] [Related]
23. ELABELA-APJ Axis Enhances Mesenchymal Stem Cell Proliferation and Migration via the METTL3/PI3K/AKT Pathway. Xu D; Fu J; Liu X; Hong Y; Chen X; Li S; Hou J; Zhang K; Zhou C; Zeng C; Zheng G; Wu H; Wang T Acta Naturae; 2024; 16(1):111-118. PubMed ID: 38698964 [TBL] [Abstract][Full Text] [Related]
24. Nephropathy Is Aggravated by Fatty Acids in Diabetic Kidney Disease through Tubular Epithelial Cell Necroptosis and Is Alleviated by an RIPK-1 Inhibitor. Yu Q; Chen Y; Zhao Y; Huang S; Xin X; Jiang L; Wang H; Wu W; Qu L; Xiang C; Wang S; Liu G; Yang L Kidney Dis (Basel); 2023 Oct; 9(5):408-423. PubMed ID: 37927402 [TBL] [Abstract][Full Text] [Related]
25. ELABELA and an ELABELA Fragment Protect against AKI. Chen H; Wang L; Wang W; Cheng C; Zhang Y; Zhou Y; Wang C; Miao X; Wang J; Wang C; Li J; Zheng L; Huang K J Am Soc Nephrol; 2017 Sep; 28(9):2694-2707. PubMed ID: 28583915 [TBL] [Abstract][Full Text] [Related]
26. Elabela Attenuates the TGF-β1-Induced Epithelial-Mesenchymal Transition of Peritoneal Mesothelial Cells in Patients Receiving Peritoneal Dialysis. Xie S; Xu F; Lu Y; Zhang Y; Li X; Yu M; Cui W Front Pharmacol; 2022; 13():890881. PubMed ID: 35800446 [TBL] [Abstract][Full Text] [Related]
27. Trigonelline inhibits tubular epithelial-mesenchymal transformation in diabetic kidney disease via targeting Smad7. Gong M; Guo Y; Dong H; Wu W; Wu F; Lu F Biomed Pharmacother; 2023 Dec; 168():115747. PubMed ID: 37864898 [TBL] [Abstract][Full Text] [Related]
28. Decreased secretion and profibrotic activity of tubular exosomes in diabetic kidney disease. Wen J; Ma Z; Livingston MJ; Zhang W; Yuan Y; Guo C; Liu Y; Fu P; Dong Z Am J Physiol Renal Physiol; 2020 Oct; 319(4):F664-F673. PubMed ID: 32715764 [TBL] [Abstract][Full Text] [Related]
29. Elabela-APJ axis attenuates cerebral ischemia/reperfusion injury by inhibiting neuronal ferroptosis. Xu P; Kong L; Tao C; Zhu Y; Cheng J; Li W; Shen N; Li R; Zhang C; Wang L; Zhang Y; Wang G; Liu X; Sun W; Hu W Free Radic Biol Med; 2023 Feb; 196():171-186. PubMed ID: 36681202 [TBL] [Abstract][Full Text] [Related]
30. ELABELA Improves Cardio-Renal Outcome in Fatal Experimental Septic Shock. Coquerel D; Chagnon F; Sainsily X; Dumont L; Murza A; Côté J; Dumaine R; Sarret P; Marsault É; Salvail D; Auger-Messier M; Lesur O Crit Care Med; 2017 Nov; 45(11):e1139-e1148. PubMed ID: 28777197 [TBL] [Abstract][Full Text] [Related]
31. Apelin/Elabela-APJ: a novel therapeutic target in the cardiovascular system. Liu W; Yan J; Pan W; Tang M Ann Transl Med; 2020 Mar; 8(5):243. PubMed ID: 32309390 [TBL] [Abstract][Full Text] [Related]
32. Wogonin protects glomerular podocytes by targeting Bcl-2-mediated autophagy and apoptosis in diabetic kidney disease. Liu XQ; Jiang L; Li YY; Huang YB; Hu XR; Zhu W; Wang X; Wu YG; Meng XM; Qi XM Acta Pharmacol Sin; 2022 Jan; 43(1):96-110. PubMed ID: 34253875 [TBL] [Abstract][Full Text] [Related]
33. Baicalin ameliorates renal fibrosis by upregulating CPT1α-mediated fatty acid oxidation in diabetic kidney disease. Hu H; Li W; Hao Y; Peng Z; Zou Z; Liang W Phytomedicine; 2024 Jan; 122():155162. PubMed ID: 37922789 [TBL] [Abstract][Full Text] [Related]
34. Huangkui capsule attenuates diabetic kidney disease through the induction of mitophagy mediated by STING1/PINK1 signaling in tubular cells. Zhu Z; Luan G; Peng S; Fang Y; Fang Q; Shen S; Wu K; Qian S; Jia W; Ye J; Wei L Phytomedicine; 2023 Oct; 119():154975. PubMed ID: 37517171 [TBL] [Abstract][Full Text] [Related]
35. MicroRNA-122 aggravates angiotensin II-mediated apoptosis and autophagy imbalance in rat aortic adventitial fibroblasts via the modulation of SIRT6-elabela-ACE2 signaling. Song JJ; Yang M; Liu Y; Song JW; Wang J; Chi HJ; Liu XY; Zuo K; Yang XC; Zhong JC Eur J Pharmacol; 2020 Sep; 883():173374. PubMed ID: 32682786 [TBL] [Abstract][Full Text] [Related]
36. Yishen Tongluo formula alleviates diabetic kidney disease through regulating Sirt6/TGF-β1/Smad2/3 pathway and promoting degradation of TGF-β1. Zhang X; Zhao L; Xiang S; Sun Y; Wang P; Chen JJ; Teo BS; Xie Z; Zhang Z; Xu J J Ethnopharmacol; 2023 May; 307():116243. PubMed ID: 36791927 [TBL] [Abstract][Full Text] [Related]
37. Senescent renal tubular epithelial cells activate fibroblasts by secreting Shh to promote the progression of diabetic kidney disease. Wang D; Yin L; Chen R; Tan W; Liang L; Xiang J; Zhang H; Zhou X; Deng H; Guo B; Wang Y Front Med (Lausanne); 2022; 9():1018298. PubMed ID: 36760880 [TBL] [Abstract][Full Text] [Related]
38. Therapeutic potential of apelin and Elabela in cardiovascular disease. Gao S; Chen H Biomed Pharmacother; 2023 Oct; 166():115268. PubMed ID: 37562237 [TBL] [Abstract][Full Text] [Related]
39. Fc-Elabela fusion protein attenuates lipopolysaccharide-induced kidney injury in mice. Xu F; Zhou H; Wu M; Zhang H; Zhang Y; Zhao Q; Brown R; Gong DW; Miao L Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32808659 [TBL] [Abstract][Full Text] [Related]
40. Expression of apelin‑13 and its negative correlation with TGF‑β1 in patients with diabetic kidney disease. Wang Q; Liu X; Zhai A; Xu H; Ma S; Liu Y Exp Ther Med; 2024 Mar; 27(3):110. PubMed ID: 38361517 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]